COVID’19, to Pump More than Usual Investments in India’s Healthcare Industry- “Preparedness” is what “Prescribed” to the Private Players
Challenging Times often Brings out the Best Out of Us and the Current Pandemic is likely to Offer Similar When it Comes to the Indian Healthcare Industry
At outset of this new decade 2020, the world witnessed one of the biggest and toughest health crisis in the form of COVID’19. About 4.7 lakh people across the globe succumbed their lives to this pandemic over a span of just six months as on June 2020, with a count of infected one’s hovering around 90 lakhs. The scenario has been so critical that even the countries with best health infrastructure has been short on providing adequate medical facilities, with more and more cases getting registered every day. India being no different is also coping up with this tough time. It is pertinent to note that as on June 2020, the total COVID’19 positive cases in India stands to be 4.25 lakhs, i.e. approximately 5% of the total infected cases globally. Further, the country accounts nearly 3% of the total global deaths due to the current pandemic. But challenging times often brings out the best out of us, a great opportunity is underlying beneath the tough times and is likely to better shape the growth of healthcare industry in India. The experiences gained during this time has demonstrated the potential fundamental shifts across the healthcare and well being continuum. These shifts include the design and construction of facilities, the training of healthcare workers, sourcing and inventory management of critical care equipment and personal protective equipment (PPE) materials, and the optimal settings for care delivery and how it is reimbursed. Some of these shifts were underway in the country before the pandemic was declared and likely will now be accelerated.
Infact, well advance of the current scenario , government of India recognized the need to reform the existing healthcare industry in the country. The testimony of this fact lies in the budgetary allocation of INR 690 Billion done for the sector in Union Budget 2020-21 on February 1, 2020. Not only this, the government also announced the expansion of its Ayushman Bharat scheme with setting up of more hospitals in Tier-II and Tier III cities of India through public private partnership (PPP) mode. Not only in setting hospital infra, but government is enhancing private participation across the healthcare industry. One of the biggest example of this is mushrooming of start-ups scaling virtual health offerings such as telemedicine. It is significant to note that many major hospitals in India have adopted telemedicine services and have entered number of PPPs tie ups which is likely to increase the said market at a CAGR of 22-27% by 2025. Some of the other identified important changes that Indian health and well being industry can witness and offer a potential market for the private players are - flexible design & construction of new facilities to ensure increased number of beds with a ability to quickly convert them into intensive / critical care beds , establishing an centralized ICU hub, virtual ICUs, use of artificial intelligence for operational excellence, robotic surgeries, separating ancillary functions such as imaging & test labs from core hospitals, accelerated transition to ambulatory care, technological advancements etc.
USPs
Key Highlights
Report Insights
Must buy for
Challenging Times often Brings out the Best Out of Us and the Current Pandemic is likely to Offer Similar When it Comes to the Indian Healthcare Industry
At outset of this new decade 2020, the world witnessed one of the biggest and toughest health crisis in the form of COVID’19. About 4.7 lakh people across the globe succumbed their lives to this pandemic over a span of just six months as on June 2020, with a count of infected one’s hovering around 90 lakhs. The scenario has been so critical that even the countries with best health infrastructure has been short on providing adequate medical facilities, with more and more cases getting registered every day. India being no different is also coping up with this tough time. It is pertinent to note that as on June 2020, the total COVID’19 positive cases in India stands to be 4.25 lakhs, i.e. approximately 5% of the total infected cases globally. Further, the country accounts nearly 3% of the total global deaths due to the current pandemic. But challenging times often brings out the best out of us, a great opportunity is underlying beneath the tough times and is likely to better shape the growth of healthcare industry in India. The experiences gained during this time has demonstrated the potential fundamental shifts across the healthcare and well being continuum. These shifts include the design and construction of facilities, the training of healthcare workers, sourcing and inventory management of critical care equipment and personal protective equipment (PPE) materials, and the optimal settings for care delivery and how it is reimbursed. Some of these shifts were underway in the country before the pandemic was declared and likely will now be accelerated.
Infact, well advance of the current scenario , government of India recognized the need to reform the existing healthcare industry in the country. The testimony of this fact lies in the budgetary allocation of INR 690 Billion done for the sector in Union Budget 2020-21 on February 1, 2020. Not only this, the government also announced the expansion of its Ayushman Bharat scheme with setting up of more hospitals in Tier-II and Tier III cities of India through public private partnership (PPP) mode. Not only in setting hospital infra, but government is enhancing private participation across the healthcare industry. One of the biggest example of this is mushrooming of start-ups scaling virtual health offerings such as telemedicine. It is significant to note that many major hospitals in India have adopted telemedicine services and have entered number of PPPs tie ups which is likely to increase the said market at a CAGR of 22-27% by 2025. Some of the other identified important changes that Indian health and well being industry can witness and offer a potential market for the private players are - flexible design & construction of new facilities to ensure increased number of beds with a ability to quickly convert them into intensive / critical care beds , establishing an centralized ICU hub, virtual ICUs, use of artificial intelligence for operational excellence, robotic surgeries, separating ancillary functions such as imaging & test labs from core hospitals, accelerated transition to ambulatory care, technological advancements etc.
USPs
- First hand sector knowledge and inputs
- Primary research inputs from F2F interviews with domain experts
- Experts insights and market reviews taken into consideration
- Validated data and analysis
- Opportunity mapping and market sizing
- Germinates from minds that think fresh to evolve path finding guide for all stake holders through quality information and analysis
- Free query handling and analyst support for three months from the date of report procurement
Key Highlights
- Sneak peak of medical device & equipment manufacturing in India before and after COVID'19
- Regulatory & Policy Mechanism for manufacturing medical devices & equipments in India
- Potential market size examination of diagnostic equipments in India till 2025
- Potential market size examination of Orthopaedics & Prosthetics equipments in India till 2025
- Potential market size examination of dental equipments in India till 2025
- Potential market size examination of consumables and disposables in India till 2025
- Potential market size examination of patient aids in India till 2025
Report Insights
- Opportunity assessment for private players in Indian medical device & equipment manufacturing till 2025
- Track of players presence and competition landscaping in Indian medical device & equipment manufacturing Industry
- Likely market share assessment till 2025
- Discovering state wise investment opportunities in expanding manufacturing capabilities for medical device & equipment
- Identifying investment hotspots across Tier I, Tier II and Tier III Indian cities
- Market size assessment of ventilators in India till 2025
- Track of key certifications, compliances required for manufacturing medical device & equipments in India for both domestic and foriegn players
- Company profiling of key players in Indian medical device & equipment manufacturin
Must buy for
- Medical Equipment Manufacturers and Suppliers
- Ventilator Manufacturers
- Healthcare industry value chain players
- Medical Organizations
- Other OEMs
- Government & Regulatory Bodies
- Research Institutes
- Funding Agencies
- International Agencies
Table of Contents
- COVID-19 Impact - From ‘Next to Now’ - Current capacity track of medical device and equipments in India on state wise basis
- Regulatory and Policy Mechanism in Manufacturing Medical Device & Equipments in India
- Opportunity Assessment in Manufacturing Syringes & Needles in India Till 2025
- Opportunity Assessment in Manufacturing Consumables & Disposables in India Till 2025
- Opportunity Assessment in Manufacturing Diagnostic Equipments in India Till 2025
- Opportunity Assessment in Manufacturing Dental Products in India Till 2025
- Opportunity Assessment in Manufacturing Orthopaedics & Prosthetics Equipments in India Till 2025
- Opportunity Assessment in Manufacturing Patient Aid Equipments in India Till 2025
- Opportunity Assessment in Manufacturing Therapeutic Appliances in India Till 2025
- Opportunity Assessment in Manufacturing Ophthalmic Instruments Equipments in India Till 2025
- Opportunity Assessment in Instruments and Appliances in India Till 2025
- Opportunity Assessment in Manufacturing Ventilators in India Till 2025
- Profiling of Key Players in the Medical Device and Equipment Manufacturing Industry in India
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Philips India
- GE Healthcare India
- Thermo Fisher Scientific
- Abbot
- Siemens
- Johnson & Johnson
- TransAsia Biomedical limited
- Trivitron Healthcare
- Polymed medical device
- Hindustan Syringes and medical device limited
- Sahajanand Medical Technologies
- Meril Lifescience
- Beacon Diagnostics Pvt Limited